Longeveron share price logo

Longeveron

NASDAQ: LGVN

$6.60

-0.26

(-3.79%)

as on

Longeveron Stock Performance

as on September 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.55
    $7.15
    downward going graph

    0.76%

    Downside

    8.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.75
    $12.30
    downward going graph

    28.03%

    Downside

    86.36%

    Upside

    downward going graph

Longeveron share price movements today

Previous Close
$6.86
Open
$6.99
Volume
193.8K
Market Cap
$23.4M
Day's Low - High
$6.55 - $7.15
52 Week Low - High
$4.75 - $12.30

Longeveron Historical Returns

1 Month Return
-6.47 %
3 Month Return
-12.41 %
1 Year Return
-8.65 %
3 Year Return
-97.03 %
5 Year Return
-98.11 %

Longeveron Stock Fundamentals & Key Indicators

Check Longeveron market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.4M

EPS (TTM)

-7.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-22.4M

Revenue (TTM)

1.2M

Profit Margin

0.00%

Return On Equity TTM

-203.61%

Longeveron vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Longeveron with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$23.4M-98.11%NA0.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Longeveron Stock including INR - Dollar returns

The Longeveron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Longeveron investment value today

Current value as on today

₹95,117

Returns

-₹4,883

(-4.88%)

Returns from Longeveron Stock

-₹12,871 (-12.87%)

Dollar Impact

₹7,988 (+7.99%)

Analyst Recommendation on Longeveron Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Longeveron. Average target price of $71.5

Longeveron Share Price Target

Get share price movements and forecasts by analysts on Longeveron.

What analysts predicted

90.77%UPSIDE

Target Price

$71.5

Current Price

$6.6

Analyzed by

2 Analysts

Target

$71.50

Longeveron target price $71.5, a slight upside of 90.77% compared to current price of $6.6. According to 2 analysts rating.

Indian Investors' Interest in Longeveron Stock

Search interest for Longeveron Stock has increased by 86% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:86% versus previous 30 day period

Longeveron Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-4
-3
-4
-4
-5
-5
-7
-5
-4
-6
EBITDA
-3
-3
-4
-3
-4
-4
-6
-5
-4
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
-4
-4
-5
-5
-7
-5
-4
-6
Income Tax Expense
0
-
-
-
-
-
-
-
-
-
Net Income
-4
-3
-4
-4
-5
-5
-7
-5
-4
-6
Net Profit Margin
-740.51%
-729.27%
-571.67%
-676.78%
-1315.22%
-1591.14%
-5270.80%
-1491.51%
-1189.95%
-2116.03%

Longeveron Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
5
5
1
1
0
2
1
Gross Profit
0
1
1
0
0
0
1
0
Operating Income
-6
-3
-3
-17
-18
-21
-16
-23
EBITDA
-5
-2
-2
-16
-17
-20
-15
-21
Interest Expense
-
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
1
Income Before Tax
-6
-3
-3
-17
-18
-21
-15
-22
Income Tax Expense
0
0
0
0
0
0
-24
-
Net Income
-6
-3
-3
-17
-18
-21
-15
-22
Net Profit Margin
-296.84%
-66.09%
-66.10%
-1305.13%
-1541.33%
-3020.17%
-667.77%
-1893.58%

Longeveron Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-4
-4
-5
-5
-7
-5
-4
-6
Operating Cash Flow
-4
-2
-3
-4
-3
-5
-5
-4
-5
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
15
13
0
0
0
4
0
15
0
Change in Cash
10
10
-3
-4
-3
-1
-4
11
-5

Longeveron Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-3
-17
-18
-21
-15
-22
Operating Cash Flow
-2
-2
-9
-13
-19
-13
-18
Investing Cash Flow
0
0
-10
0
8
0
0
Financing Cash Flow
0
1
45
0
5
28
4
Change in Cash
-2
-1
24
-15
-5
14
-14

Mutual Funds that own Longeveron Stock

Check out the Mutual Funds with significant holdings in Longeveron.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
17.810683%
542032
Fidelity Concord Street Trust
3.891207%
118421

Global Institutional Holdings in Longeveron

Funds
Holdings
Vanguard
19.1%

Longeveron News & Key Events

  • img

    Today's Timeline - 16 September

    Thu, 03:05 AM

    -

    Longeveron’s laromestrocel failed to meet primary endpoint in Phase 2b HLHS trial, prompting further analysis and FDA discussions.

    Thu, 03:05 AM

    -

    Longeveron exploring options to maximize shareholder value, including cost containment and engaging a strategic advisor.

    Thu, 03:10 AM

    -

    Longeveron scheduled to resume trading at 5:55 PM ET after halt due to pending news.

  • img

    Today's Timeline - 16 September

    Thu, 03:30 AM

    -

    Longeveron trading resumes; company regains Nasdaq compliance with minimum bid price.

Insights on Longeveron

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 475.1% return, outperforming this stock by 483.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 25.5% return, outperforming this stock by 122.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, LGVN stock has moved down by -97.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -4.73M → -6.07M (in $), with an average decrease of 28.2% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 398.0K → 287.0K (in $), with an average decrease of 27.9% per quarter

About Longeveron

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
OrganisationLongeveron
HeadquartersLife Science & Technology Park, Miami, FL, United States, 33136
IndustryBiotechnology
CEOMr. Stephen H. Willard Esq.
E-voting on sharesClick here to vote

Key Management of Longeveron

Name

Title

Dr. Joshua Michael Hare FACC, M.D.

Co-Founder, Chief Science Officer & Executive Chairman

Mr. Nirav Suresh Jhaveri C.F.A., M.B.A.

CFO and Principal Financial & Accounting Officer

Dr. Nataliya Agafonova M.D.

Chief Medical Officer

Ms. Lisa McClain-Moss

Vice President of Manufacturing

Mr. Paul T. Lehr J.D.

General Counsel & Secretary

Mr. Stephen H. Willard Esq.

CEO & Director

Mr. Devin Blass

CTO and Senior VP of Chemistry, Manufacturing & Controls

Ms. Marie Washburn

VP & Corporate Controller

Mr. Brian G Rash Ph.D.

Vice President of Research & Discovery

FAQs

What is Longeveron share price today?

Longeveron share price today is $6.60 as on at the close of the market. Longeveron share today touched a day high of $7.15 and a low of $6.55.

What is the 52 week high and 52 week low for Longeveron share?

Longeveron share touched a 52 week high of $12.30 on and a 52 week low of $4.75 on . Longeveron stock price today i.e. is closed at $6.60,which is 46.34% down from its 52 week high and 38.95% up from its 52 week low.

What is Longeveron's market capitalisation today?

Longeveron market capitalisation is $0.00T as on .

How to invest in Longeveron Stock (LGVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Longeveron on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Longeveron Shares that will get you 0.2273 shares as per Longeveron share price of $6.60 per share as on September 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy Longeveron Stock (LGVN) from India?

Indian investors can start investing in Longeveron (LGVN) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Longeveron stock (as per the Rupee-Dollar exchange rate as on ). Based on Longeveron share’s latest price of $6.60 as on September 17, 2026 at 1:29 am IST, you will get 1.5152 shares of Longeveron. Learn more about fractional shares .

What are the returns that Longeveron has given to Indian investors in the last 5 years?

Longeveron stock has given -98.11% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?